Koyfin Home > Directory > Health Care > Antares Pharma > Total Debt / Equity

Antares Pharma Total Debt / Equity Chart (ATRS)

Antares Pharma annual/quarterly Total Debt / Equity from 2017 to 2020. Debt to equity is a measure of leverage in a company and expressed as a ratio of the total debt relative to book value of equity.
  • Antares Pharma Total Debt / Equity for the quarter ending March 03, 2020 was $87m a -17.94% decrease of -16m year over year
  • Antares Pharma Total Debt / Equity for the last 12 months ending March 03, 2020 was $87m a -17.94% decrease of -16m year over year
  • Antares Pharma Annual Total Debt / Equity for 2019 was $86m a 25.43% increase of 22m from 2018
  • Antares Pharma Annual Total Debt / Equity for 2018 was $64m a -15.02% decrease of -10m from 2017
  • Antares Pharma Annual Total Debt / Equity for 2017 was $74m
Other Ratios Metrics:
  • Antares Pharma Total Debt / Capital for the quarter ending December 12, 2018 was $39m a -19.64% decrease of -8m year over year
  • Antares Pharma Other Liabilities for the quarter ending September 09, 2018 was $0m a 0.00% decrease of 0m year over year
View Chart On Koyfin

Quarterly ATRS Total Debt / Equity Data

03/2020$87m
12/2019$86m
09/2019$103m
06/2019$103m
03/2019$64m
12/2018$64m
09/2018$103m
06/2018$101m
03/2018$88m
12/2017$74m

Annual ATRS Total Debt / Equity Data

2019$86m
2018$64m
2017$74m